IBDEI1F9 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23000,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,23000,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,23001,0)
 ;;=C50.912^^78^995^8
 ;;^UTILITY(U,$J,358.3,23001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23001,1,3,0)
 ;;=3^Malignant neoplasm of left female breast,unspec site
 ;;^UTILITY(U,$J,358.3,23001,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,23001,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,23002,0)
 ;;=C64.2^^78^995^9
 ;;^UTILITY(U,$J,358.3,23002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23002,1,3,0)
 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,23002,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,23002,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,23003,0)
 ;;=C61.^^78^995^10
 ;;^UTILITY(U,$J,358.3,23003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23003,1,3,0)
 ;;=3^Malignant neoplasm of prostate
 ;;^UTILITY(U,$J,358.3,23003,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,23003,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,23004,0)
 ;;=C34.91^^78^995^11
 ;;^UTILITY(U,$J,358.3,23004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23004,1,3,0)
 ;;=3^Malignant neoplasm of right bronchus/lung,unspec part
 ;;^UTILITY(U,$J,358.3,23004,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,23004,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,23005,0)
 ;;=C50.911^^78^995^12
 ;;^UTILITY(U,$J,358.3,23005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23005,1,3,0)
 ;;=3^Malignant neoplasm of right female breast,unspec site
 ;;^UTILITY(U,$J,358.3,23005,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,23005,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,23006,0)
 ;;=C64.1^^78^995^13
 ;;^UTILITY(U,$J,358.3,23006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23006,1,3,0)
 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,23006,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,23006,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,23007,0)
 ;;=C44.99^^78^995^14
 ;;^UTILITY(U,$J,358.3,23007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23007,1,3,0)
 ;;=3^Malignant neoplasm of skin,Oth Spec
 ;;^UTILITY(U,$J,358.3,23007,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,23007,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,23008,0)
 ;;=C79.51^^78^995^15
 ;;^UTILITY(U,$J,358.3,23008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23008,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,23008,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,23008,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,23009,0)
 ;;=C79.52^^78^995^16
 ;;^UTILITY(U,$J,358.3,23009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23009,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone marrow
 ;;^UTILITY(U,$J,358.3,23009,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,23009,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,23010,0)
 ;;=D47.4^^78^996^29
 ;;^UTILITY(U,$J,358.3,23010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23010,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,23010,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,23010,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,23011,0)
 ;;=D50.9^^78^996^1
 ;;^UTILITY(U,$J,358.3,23011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23011,1,3,0)
 ;;=3^Anemia, iron deficiency
 ;;^UTILITY(U,$J,358.3,23011,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,23011,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,23012,0)
 ;;=D64.9^^78^996^2
 ;;^UTILITY(U,$J,358.3,23012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23012,1,3,0)
 ;;=3^Anemia, unspecified
